Icosavax Inc

Company Profile

Icosavax Inc had its IPO on 2021-07-29 under the ticker symbol ICVX.

The company operates in the Healthcare sector and Biotechnology industry. Icosavax Inc has a staff strength of 60 employees.

Stock update

Shares of Icosavax Inc opened at $7.47 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.03 - $7.57, and closed at $7.34.

This is a -2.39% slip from the previous day's closing price.

A total volume of 153,057 shares were traded at the close of the day’s session.

In the last one week, shares of Icosavax Inc have slipped by -5.66%.

Icosavax Inc's Key Ratios

Icosavax Inc has a market cap of $389.36 million, indicating a price to book ratio of 1.5772 and a price to sales ratio of 153.3126.

In the last 12-months Icosavax Inc’s revenue was $0 with a gross profit of $-30974000 and an EBITDA of $-101681000. The EBITDA ratio measures Icosavax Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Icosavax Inc’s operating margin was 0% while its return on assets stood at -24.53% with a return of equity of -39.44%.

In Q2, Icosavax Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Icosavax Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.33 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Icosavax Inc’s profitability.

Icosavax Inc stock is trading at a EV to sales ratio of 34.1819 and a EV to EBITDA ratio of -1.5896. Its price to sales ratio in the trailing 12-months stood at 153.3126.

Icosavax Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$269.03 million

Total Liabilities

$15.01 million

Operating Cash Flow

$0

Capital Expenditure

$679000

Dividend Payout Ratio

0%

Icosavax Inc ended 2024 with $269.03 million in total assets and $0 in total liabilities. Its intangible assets were valued at $269.03 million while shareholder equity stood at $247.72 million.

Icosavax Inc ended 2024 with $0 in deferred long-term liabilities, $15.01 million in other current liabilities, 7000.00 in common stock, $-236885000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $155.07 million and cash and short-term investments were $246.93 million. The company’s total short-term debt was $2,169,000 while long-term debt stood at $0.

Icosavax Inc’s total current assets stands at $251.70 million while long-term investments were $0 and short-term investments were $91.86 million. Its net receivables were $0 compared to accounts payable of $1.55 million and inventory worth $0.

In 2024, Icosavax Inc's operating cash flow was $0 while its capital expenditure stood at $679000.

Comparatively, Icosavax Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$7.34

52-Week High

$11.99

52-Week Low

$2.28

Analyst Target Price

$23.33

Icosavax Inc stock is currently trading at $7.34 per share. It touched a 52-week high of $11.99 and a 52-week low of $11.99. Analysts tracking the stock have a 12-month average target price of $23.33.

Its 50-day moving average was $8.38 and 200-day moving average was $8.05 The short ratio stood at 6.94 indicating a short percent outstanding of 0%.

Around 371.6% of the company’s stock are held by insiders while 7174.1% are held by institutions.